We have found 410 documents matching your search criteria

  1. From sludge to fertilizer: recycling gelatin's waste stream at Isle sur la Sorgue

    When gelatin is extracted from bones, sludge is generated in so-called waste streams. However, these streams don’t need to be wasted; instead, they can be upcycled for sustainability. In this article, we will explore how the sludge from gelatin’s water treatment process has been used as an agricultu

  2. Rousselot® Biomedical announces the world's first GMP grade GelMA

    The production of X-Pure GelMA under GMP conditions is a major step forward for companies that require GelMA for clinical use and in body medical applications. Up until now, research grade GelMA was the only available option. The GMP process ensures that Rousselot X-pure GelMAs are consistently prod

  3. Rousselot® obtains patent for StabiCaps™ gelatin for soft gels

    Due to its natural properties, functional benefits and suitability for immediate release dosing, gelatin is the most common gel forming agent used in soft gel production (2) . Launched in 2018, StabiCaps features gelatins that offer superior shell stability and Active Pharmaceutical Ingredient (API)

  4. Students explore sustainability at Rousselot-sponsored farm in Brazil

    Merging agriculture and education in Sitio Duas Cachoeiras Sitio Duas Cachoeiras is located in a rural area in southeast Brazil’s Mantiqueira mountain range, with parts spreading into the states of São Paulo, Minas Gerais, and Rio de Janeiro. The farm merges ecological agriculture with education in

  5. Rousselot® Biomedical announces the launch of Quali-PureTM HGP 2000

    Quali-Pure HGP 2000 for vaccines and wound healing Gelatin, in its non-gelling hydrolyzed form, has long been used as a protein or peptide excipient in vaccine formulations due to its natural biocompatibility and biodegradability and its ability to stabilize vaccines. When used in wound healing, gel

  6. Two health innovations we launched in 2021

    In 2021, we launched two innovations: X-Pure®, GelDAT® Launched in May ‘21 A highly purified gelatin from the X-Pure range , GelDAT® is ideal for research and preclinical development in regenerative medicine, drug release, cell culture, and complex wound dressings. Quali-Pure® Launched in October ‘2

  7. Rousselot Biomedical in the media

    Rousselot Biomedical in the media The potential of gelatin to optimize cell line development workflows European Biopharmaceutical Review October 2022, pages 68-70. © Samedan Ltd. Optimal gelatin-base biomaterial Medical Device development, 2022, Vol 1 Biomaterials: Challenges, Characteristics, and C

  8. Rousselot® brings unique hair beauty experience to IN-COSMETICS GLOBAL 2022 with ingestible Peptan® collagen peptides

    Nurturing hair beauty from the root with ingestible collagen peptides In the beauty market, there is currently a high demand for nutricosmetic products offering skin and hair beauty benefits. In the hair beauty segment, beyond the classic personal care products, consumers are increasingly relying on

  9. Quali-Pure gelatin | Endotoxin controlled | Batch to Batch consistency

    Quali-Pure What is Quali-Pure? The Quali-Pure ® range of clinical grade gelatins offers medical manufacturers endotoxin-controlled gelatins, providing guaranteed biocompatibility, biodegradability, and batch-to-batch consistency. It is designed to meet high quality and safety standards. The whole ra

  10. Ir. Tanja Vervust

    Ir. Tanja Vervust Global Director, Rousselot Biomedical Tanja holds an MSc in Bioscience Engineering from Ghent University and has over 25 years of experience with Rousselot. In January 2018, Tanja was appointed Global Director Rousselot Biomedical. Which aspect of your work inspires you the most? A